-
1
-
-
24944521199
-
Schizophrenia practice guidelines: international survey and comparison
-
Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS. Schizophrenia practice guidelines: international survey and comparison. BJPsych 2005;187:248-255.
-
(2005)
BJPsych
, vol.187
, pp. 248-255
-
-
Gaebel, W.1
Weinmann, S.2
Sartorius, N.3
Rutz, W.4
McIntyre, J.S.5
-
2
-
-
0004050325
-
-
American Psychiatric Association., 2nd edn. Arlington, VA: American Psychiatric Association
-
American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia, 2nd edn. Arlington, VA: American Psychiatric Association, 2004.
-
(2004)
Practice guideline for the treatment of patients with schizophrenia
-
-
-
3
-
-
73949157937
-
The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009
-
Kreyenbuhl J, Buchanan R, Dickerson FB, Dixon LB. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull 2010;36:94-103.
-
(2010)
Schizophr Bull
, vol.36
, pp. 94-103
-
-
Kreyenbuhl, J.1
Buchanan, R.2
Dickerson, F.B.3
Dixon, L.B.4
-
4
-
-
1842533044
-
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits
-
Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry 2004;161:700-706.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 700-706
-
-
Centorrino, F.1
Goren, J.L.2
Hennen, J.3
Salvatore, P.4
Kelleher, J.P.5
Baldessarini, R.J.6
-
6
-
-
65349112410
-
Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials
-
Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull 2009;35:443-457.
-
(2009)
Schizophr Bull
, vol.35
, pp. 443-457
-
-
Correll, C.U.1
Rummel-Kluge, C.2
Corves, C.3
Kane, J.M.4
Leucht, S.5
-
7
-
-
85016038379
-
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
-
Cipriani A, Boso M, Barbui C. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database Syst Rev 2009;8(3):CD006324.
-
(2009)
Cochrane Database Syst Rev
, vol.8
, Issue.3
-
-
Cipriani, A.1
Boso, M.2
Barbui, C.3
-
8
-
-
65849514380
-
Polypharmacy with second-generation antipsychotics: a review of evidence
-
Pandurangi AK, Dalkilic A. Polypharmacy with second-generation antipsychotics: a review of evidence. J Psychiatr Pract 2008;14:345-367.
-
(2008)
J Psychiatr Pract
, vol.14
, pp. 345-367
-
-
Pandurangi, A.K.1
Dalkilic, A.2
-
9
-
-
26844433208
-
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
-
Faries D, Ascher-Svanum H, Zhu B, Correll C, Kane J. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 2005;5:26.
-
(2005)
BMC Psychiatry
, vol.5
, pp. 26
-
-
Faries, D.1
Ascher-Svanum, H.2
Zhu, B.3
Correll, C.4
Kane, J.5
-
10
-
-
1242329378
-
A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation
-
Stahl SM, Grady MM. A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr Med Chem 2004;11:313-326.
-
(2004)
Curr Med Chem
, vol.11
, pp. 313-326
-
-
Stahl, S.M.1
Grady, M.M.2
-
11
-
-
77957341547
-
Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients
-
Baandrup L, Allerup P, Lublin H, Nordentoft M, Peacock L, Glenthoj B. Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients. Acta Psychiatr Scand 2010;122:367-374.
-
(2010)
Acta Psychiatr Scand
, vol.122
, pp. 367-374
-
-
Baandrup, L.1
Allerup, P.2
Lublin, H.3
Nordentoft, M.4
Peacock, L.5
Glenthoj, B.6
-
12
-
-
72249120193
-
Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies
-
Verdoux H, Tour M. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand 2010;121:4-10.
-
(2010)
Acta Psychiatr Scand
, vol.121
, pp. 4-10
-
-
Verdoux, H.1
Tour, M.2
-
13
-
-
0035988519
-
Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy
-
Clark RE, Bartels SJ, Mellman TA, Peacock WJ. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull 2002;28:75-84.
-
(2002)
Schizophr Bull
, vol.28
, pp. 75-84
-
-
Clark, R.E.1
Bartels, S.J.2
Mellman, T.A.3
Peacock, W.J.4
-
15
-
-
77957348105
-
10-year trends in the treatment and outcomes of patients with first-episode schizophrenia
-
Nielsen J, Le Quach P, Emborg C, Foldager L, Correll CU. 10-year trends in the treatment and outcomes of patients with first-episode schizophrenia. Acta Psychiatr Scand 2010;122:356-366.
-
(2010)
Acta Psychiatr Scand
, vol.122
, pp. 356-366
-
-
Nielsen, J.1
Le Quach, P.2
Emborg, C.3
Foldager, L.4
Correll, C.U.5
-
16
-
-
43049140470
-
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
-
Zhu B, Ascher-Svanum H, Faries DE, Correll CU, Kane JM. Cost of antipsychotic polypharmacy in the treatment of schizophrenia. BMC Psychiatry 2008;8:19.
-
(2008)
BMC Psychiatry
, vol.8
, pp. 19
-
-
Zhu, B.1
Ascher-Svanum, H.2
Faries, D.E.3
Correll, C.U.4
Kane, J.M.5
-
17
-
-
73649097613
-
National trends in psychotropic medication polypharmacy in office-based psychiatry
-
Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry 2010;67:26-36.
-
(2010)
Arch Gen Psychiatry
, vol.67
, pp. 26-36
-
-
Mojtabai, R.1
Olfson, M.2
-
18
-
-
34247371922
-
Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns
-
Kreyenbuhl JA, Valenstein M, Mccarthy JF, Ganoczy D, Blow FC. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns. Psychiatr Serv 2006;58:489-495.
-
(2006)
Psychiatr Serv
, vol.58
, pp. 489-495
-
-
Kreyenbuhl, J.A.1
Valenstein, M.2
Mccarthy, J.F.3
Ganoczy, D.4
Blow, F.C.5
-
20
-
-
65349163482
-
Does the addition of a second antipsychotic drug improve clozapine treatment?
-
Barbui C, Signoretti A, Mule S, Boso M, Cipriani A. Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophr Bull 2009;35:458-468.
-
(2009)
Schizophr Bull
, vol.35
, pp. 458-468
-
-
Barbui, C.1
Signoretti, A.2
Mule, S.3
Boso, M.4
Cipriani, A.5
-
21
-
-
67649695935
-
Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study
-
Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jorgensen HA. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry 2009;9:24.
-
(2009)
BMC Psychiatry
, vol.9
, pp. 24
-
-
Kroken, R.A.1
Johnsen, E.2
Ruud, T.3
Wentzel-Larsen, T.4
Jorgensen, H.A.5
-
22
-
-
0036838758
-
Antipsychotic combination therapy in schizophrenia: a review of efficacy and risks of current combinations
-
Freudenreich O, Goff DC. Antipsychotic combination therapy in schizophrenia: a review of efficacy and risks of current combinations. Acta Psychiatr Scand 2002;106:323-330.
-
(2002)
Acta Psychiatr Scand
, vol.106
, pp. 323-330
-
-
Freudenreich, O.1
Goff, D.C.2
-
23
-
-
79960551424
-
Effectiveness of switching from antipsychotic polypharmacy to monotherapy
-
Essock SM, Schooler NR, Stroup TS et al. Effectiveness of switching from antipsychotic polypharmacy to monotherapy. Am J Psychiatry 2011;168:702-708.
-
(2011)
Am J Psychiatry
, vol.168
, pp. 702-708
-
-
Essock, S.M.1
Schooler, N.R.2
Stroup, T.S.3
-
24
-
-
73949137552
-
The 2009 schizophrenia PORT psychopharmacological treatment recommendation and summary statements
-
Buchanan RW, Kreyenbuhl J, Kelly DL et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendation and summary statements. Schizophr Bull 2010;36:71-93.
-
(2010)
Schizophr Bull
, vol.36
, pp. 71-93
-
-
Buchanan, R.W.1
Kreyenbuhl, J.2
Kelly, D.L.3
-
25
-
-
0024760391
-
The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation
-
Kay SR, Opler LA, Lindemeyer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 1989;155:59-65.
-
(1989)
Br J Psychiatry
, vol.155
, pp. 59-65
-
-
Kay, S.R.1
Opler, L.A.2
Lindemeyer, J.P.3
-
26
-
-
0004235298
-
-
American Psychiatric Association., 4th edn, Text Revision. Edited by Washington DC: American Psychiatric Association
-
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, Text Revision. Edited by Washington DC: American Psychiatric Association, 2000.
-
(2000)
Diagnostic and statistical manual of mental disorders
-
-
-
27
-
-
0014723449
-
A rating scale for extrapyramidal side effects
-
Simpson G, Angus J. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212:11-19.
-
(1970)
Acta Psychiatr Scand
, vol.212
, pp. 11-19
-
-
Simpson, G.1
Angus, J.2
-
28
-
-
0021846840
-
Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale
-
Lane RD, Glazer WM, Hansen TE, Berman WH, Kramer SI. Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale. J Nerv Ment Dis 1985;173:353-357.
-
(1985)
J Nerv Ment Dis
, vol.173
, pp. 353-357
-
-
Lane, R.D.1
Glazer, W.M.2
Hansen, T.E.3
Berman, W.H.4
Kramer, S.I.5
-
29
-
-
0033660612
-
Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile - European Version. EPSILON Study 8. European Psychiatric Services: inputs linked to outcome domains and needs
-
Gaite L, Vázquez-Barquero JL, Arrizabalaga A et al. Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile - European Version. EPSILON Study 8. European Psychiatric Services: inputs linked to outcome domains and needs. Br J Psychiatry Suppl 2000;39:s49-s54.
-
(2000)
Br J Psychiatry Suppl
, vol.39
-
-
Gaite, L.1
Vázquez-Barquero, J.L.2
Arrizabalaga, A.3
-
30
-
-
0034607573
-
Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses
-
Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000;42:241-247.
-
(2000)
Schizophr Res
, vol.42
, pp. 241-247
-
-
Thompson, K.1
Kulkarni, J.2
Sergejew, A.A.3
-
31
-
-
0033937434
-
Client Sociodemographic and Service Receipt Inventory- European Version
-
Chisholm D, Knapp M, Knudsen HC et al. Client Sociodemographic and Service Receipt Inventory- European Version. Br J Psychiatry Suppl 2000;39:S28-S33.
-
(2000)
Br J Psychiatry Suppl
, vol.39
-
-
Chisholm, D.1
Knapp, M.2
Knudsen, H.C.3
-
32
-
-
0038266756
-
Chlorpromazine equivalent doses for the newer atypical antipsychotics
-
Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-667.
-
(2003)
J Clin Psychiatry
, vol.64
, pp. 663-667
-
-
Woods, S.W.1
-
33
-
-
73549110068
-
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs
-
Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010;67:255-262.
-
(2010)
Biol Psychiatry
, vol.67
, pp. 255-262
-
-
Andreasen, N.C.1
Pressler, M.2
Nopoulos, P.3
Miller, D.4
Ho, B.C.5
-
34
-
-
77952974468
-
International consensus study of antipsychotic dosing
-
Gardner DM, Murphy AL, O'donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry 2010;167:686-693.
-
(2010)
Am J Psychiatry
, vol.167
, pp. 686-693
-
-
Gardner, D.M.1
Murphy, A.L.2
O'donnell, H.3
Centorrino, F.4
Baldessarini, R.J.5
-
35
-
-
0030912203
-
Chlorpromazine equivalents: a consensus of opinion for both clinical and research
-
Atkins M, Burgess A, Bottomley C, Riccio M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research. Psychiatr Bull 1997;21:224-226.
-
(1997)
Psychiatr Bull
, vol.21
, pp. 224-226
-
-
Atkins, M.1
Burgess, A.2
Bottomley, C.3
Riccio, M.4
-
36
-
-
34547685932
-
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses
-
Swanson JM, Hinshaw SP, Arnold LE et al. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry 2007;46:1003-1014.
-
(2007)
J Am Acad Child Adolesc Psychiatry
, vol.46
, pp. 1003-1014
-
-
Swanson, J.M.1
Hinshaw, S.P.2
Arnold, L.E.3
-
37
-
-
21244503152
-
The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial
-
Kilian R, Angermeyer MC. The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial. Qual Life Res 2005;14:1275-1289.
-
(2005)
Qual Life Res
, vol.14
, pp. 1275-1289
-
-
Kilian, R.1
Angermeyer, M.C.2
-
38
-
-
3543135271
-
Tutorial in biostatistics. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
-
D'agostino RB. Tutorial in biostatistics. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281.
-
(1998)
Stat Med
, vol.17
, pp. 2265-2281
-
-
D'agostino, R.B.1
-
39
-
-
0004296209
-
-
5th edn. Upper Saddle River: Prentice Hall
-
Greene WH. Econometric analysis, 5th edn. Upper Saddle River: Prentice Hall, 2003.
-
(2003)
Econometric analysis
-
-
Greene, W.H.1
-
40
-
-
31644450063
-
-
Stata Corporation. College Station, TX: StataCorp LP
-
Stata Corporation. Stata statistical software: release 10. College Station, TX: StataCorp LP, 2007.
-
(2007)
Stata statistical software: release 10
-
-
-
41
-
-
77952633076
-
Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients
-
Procyshyn RM, Honer WG, Wu TK et al. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. J Clin Psychiatry 2010;71:566-573.
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 566-573
-
-
Procyshyn, R.M.1
Honer, W.G.2
Wu, T.K.3
-
42
-
-
77649122136
-
Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study
-
Baandrup L, Gasse C, Jensen VD et al. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study. J Clin Psychiatry 2010;71:103-108.
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 103-108
-
-
Baandrup, L.1
Gasse, C.2
Jensen, V.D.3
-
43
-
-
78649331683
-
Trends in adult antipsychotic polypharmacy: progress and challenges in Florida's Medicaid Program
-
Constantine RJ, Andel R, Tandon R. Trends in adult antipsychotic polypharmacy: progress and challenges in Florida's Medicaid Program. Community Ment Health J 2010;46:523-530.
-
(2010)
Community Ment Health J
, vol.46
, pp. 523-530
-
-
Constantine, R.J.1
Andel, R.2
Tandon, R.3
-
45
-
-
0036839285
-
Antipsychotic polypharmacy, evidence based or eminence based?
-
Stahl SM. Antipsychotic polypharmacy, evidence based or eminence based? Acta Psychiatr Scand 2002;106:321-323.
-
(2002)
Acta Psychiatr Scand
, vol.106
, pp. 321-323
-
-
Stahl, S.M.1
-
46
-
-
0034509321
-
Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome
-
Möller HJ, Bottlender R, Wegner U, Wittmann J, Strauss A. Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome. Acta Psychiatr Scand 2000;407:54-57.
-
(2000)
Acta Psychiatr Scand
, vol.407
, pp. 54-57
-
-
Möller, H.J.1
Bottlender, R.2
Wegner, U.3
Wittmann, J.4
Strauss, A.5
-
47
-
-
0033763239
-
Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms
-
Harrow M, Grossman LS, Herbener ES, Davies EW. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry 2000;177:421-426.
-
(2000)
Br J Psychiatry
, vol.177
, pp. 421-426
-
-
Harrow, M.1
Grossman, L.S.2
Herbener, E.S.3
Davies, E.W.4
|